Notice2024-15792
Solicitation of Nominations for Appointment to the Advisory Committee on Immunization Practices
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 18, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS) is seeking nominations for membership on the Advisory Committee on Immunization Practices (ACIP). The ACIP consists of up to 19 experts in fields associated with immunization practices and public health, use of vaccines and other immunobiological agents in clinical practice or preventive medicine, clinical or laboratory vaccine research, assessment of vaccine efficacy and safety, or have knowledge about consumer perspectives and/or social and community aspects of immunization programs.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 138 (Thursday, July 18, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 138 (Thursday, July 18, 2024)]
[Notices]
[Pages 58378-58379]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-15792]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Committee on Immunization Practices
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), within the Department
of Health and Human Services (HHS) is seeking nominations for
membership on the Advisory Committee on Immunization Practices (ACIP).
The ACIP consists of up to 19 experts in fields associated with
immunization practices and public health, use of vaccines and other
immunobiological agents in clinical practice or preventive medicine,
clinical or laboratory vaccine research, assessment of vaccine efficacy
and safety, or have knowledge about
[[Page 58379]]
consumer perspectives and/or social and community aspects of
immunization programs.
DATES: Nominations for membership on the ACIP must be received no later
than August 15, 2024. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations must be completed online at <a href="https://www.cdc.gov/vaccines/acip/apply-for-membership/index.html">https://www.cdc.gov/vaccines/acip/apply-for-membership/index.html</a>.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management
Specialist, Advisory Committee on Immunization Practices, National
Center for Immunization and Respiratory Diseases, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta,
Georgia 30329-4027. Telephone: (404) 639-8836; Email: <a href="/cdn-cgi/l/email-protection#83c2c0cad3c3e0e7e0ade4ecf5"><span class="__cf_email__" data-cfemail="a8e9ebe1f8e8cbcccb86cfc7de">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The Advisory Committee on Immunization
Practices (ACIP) is charged with advising the Director, Centers for
Disease Control and Prevention (CDC), on the use of immunizing agents.
In addition, under 42 U.S.C. 1396s, the Committee is mandated to
establish and periodically review and, as appropriate, revise the list
of vaccines for administration to vaccine-eligible children through the
Vaccines for Children program, along with schedules regarding dosing
interval, dosage, and contraindications to administration of vaccines.
Further, under applicable provisions of the Affordable Care Act and
section 2713 of the Public Health Service Act and implementing
regulations, immunization recommendations of ACIP that have been
approved by the Director, CDC, and appear on CDC immunization schedules
generally must be covered by applicable health plans.
Nominations are being sought for individuals who have the expertise
and qualifications necessary to contribute to the accomplishments of
the committee's objectives. Nominees will be selected based on
expertise in the fields of immunization practices, multi-disciplinary
expertise in public health, expertise in the use of vaccines and
immunologic agents in both clinical and preventive medicine, knowledge
of vaccine development, evaluation, and vaccine delivery, or knowledge
about consumer perspectives and/or social and community aspects of
immunization programs. Federal employees will not be considered for
membership. Members may be invited to serve for up to four-year terms.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of ACIP objectives (<a href="http://www.cdc.gov/vaccines/acip/index.html">http://www.cdc.gov/vaccines/acip/index.html</a>).
HHS policy stipulates that committee membership be balanced in
terms of points of view represented, and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens and cannot be full-time employees of the
U.S. Government. Current participation on Federal workgroups or prior
experience serving on a Federal advisory committee does not disqualify
a candidate; however, HHS policy is to avoid excessive individual
service on advisory committees and multiple committee memberships.
Committee members are Special Government Employees, requiring the
filing of financial disclosure reports at the beginning and annually
during their terms. CDC reviews potential candidates for ACIP
membership each year and provides a slate of nominees for consideration
to the Secretary of HHS for final selection. HHS notifies selected
candidates of their appointment near the start of the term in July
2025, or as soon as the HHS selection process is completed. Note that
the need for different expertise varies from year to year and a
candidate who is not selected in one year may be reconsidered in a
subsequent year. SGE nominees must be U.S. citizens and cannot be full-
time employees of the U.S. Government. Candidates should submit the
following items:
[squf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address)
[squf] Two letters of recommendation from professional colleagues
familiar with the candidate's work. A maximum of four letters of
recommendation will be accepted.
[cir] Letters of recommendation should not come from current ACIP
members.
[cir] At least one letter of recommendation from person(s) not
employed by HHS. Candidates may submit letter(s) from current HHS
employees if they wish, but at least one letter must be submitted by a
person not employed by an HHS agency (e.g., National Institutes of
Health, Food and Drug Administration, Substance Abuse and Mental Health
Services Administration, etc.). CDC employees should not provide
letters of recommendation.
[squf] A cover letter that includes the candidate's statement of
interest in serving on the ACIP, the qualifications and expertise that
the candidate would bring, and written evidence to support how the
candidate meets all relevant criteria.
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-15792 Filed 7-17-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 18, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.